Correlation Between Quest PharmaTech and Spero Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and Spero Therapeutics, you can compare the effects of market volatilities on Quest PharmaTech and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and Spero Therapeutics.

Diversification Opportunities for Quest PharmaTech and Spero Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Quest and Spero is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and Spero Therapeutics go up and down completely randomly.

Pair Corralation between Quest PharmaTech and Spero Therapeutics

Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the Spero Therapeutics. In addition to that, Quest PharmaTech is 1.17 times more volatile than Spero Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Spero Therapeutics is currently generating about -0.01 per unit of volatility. If you would invest  155.00  in Spero Therapeutics on September 14, 2024 and sell it today you would lose (45.00) from holding Spero Therapeutics or give up 29.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Quest PharmaTech  vs.  Spero Therapeutics

 Performance 
       Timeline  
Quest PharmaTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Quest PharmaTech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Quest PharmaTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Spero Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Quest PharmaTech and Spero Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quest PharmaTech and Spero Therapeutics

The main advantage of trading using opposite Quest PharmaTech and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.
The idea behind Quest PharmaTech and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum